Orleans Capital Management Corp Abbott Laboratories Transaction History

Orleans Capital Management Corp

$311 Million
Q3 2024

A detailed history of Orleans Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Orleans Capital Management Corp holds 23,755 shares of ABT stock, worth $2.75 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

23,755

Previous 24,055 1.25%

Holding current value

$2.75 Million

Previous $2.5 Million 8.36%

% of portfolio

0.87%

Previous 1.63%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $30,020 - $35,439	-300 Reduced 1.25%	23,755 $2.71 Million
Q2 2024 Aug 23, 2024	BUY	$100.73 - $112.44 $10,073 - $11,244	100 Added 0.42%	24,055 $2.5 Million
Q1 2024 May 22, 2024	SELL	$109.52 - $120.96 $165,922 - $183,254	-1,515 Reduced 5.95%	23,955 $2.72 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $140,245 - $171,672	1,555 Added 6.5%	25,470 $2.8 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $4,298 - $5,157	-45 Reduced 0.19%	23,915 $2.32 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $14,613 - $16,282	145 Added 0.61%	23,960 $2.61 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $12,357 - $14,497	-130 Reduced 0.54%	23,815 $2.62 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $106,436 - $123,233	-1,100 Reduced 4.39%	23,945 $2.32 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $6,124 - $7,402	-60 Reduced 0.24%	25,045 $2.72 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 0.79%	25,105 $2.97 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $14,441 - $17,682	125 Added 0.5%	25,305 $3.56 Million
Q3 2021 Nov 18, 2021	SELL	$116.66 - $129.06 $86,911 - $96,149	-745 Reduced 2.87%	25,180 $2.98 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $49,721 - $58,529	-470 Reduced 1.78%	25,925 $3.01 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $28,298 - $33,339	-260 Reduced 0.98%	26,395 $3.16 Million
Q4 2020 Feb 19, 2021	SELL	$105.0 - $114.42 $10,500 - $11,442	-100 Reduced 0.37%	26,655 $2.92 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $73,312 - $89,032	800 Added 3.08%	26,755 $2.91 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.99 Million - $2.54 Million	25,955 New	25,955 $2.37 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.63 Million - $2.38 Million	-25,870 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $5,888 - $6,555	75 Added 0.29%	25,870 $2.25 Million
Q3 2019 Nov 15, 2019	BUY	$81.84 - $88.74 $299,534 - $324,788	3,660 Added 16.53%	25,795 $2.16 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $1.61 Million - $1.88 Million	22,135 New	22,135 $1.86 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orleans Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Orleans Capital Management Corp with notifications on news.

Account

Orleans Capital Management Corp Abbott Laboratories Transaction History